GIBRALT Trademark

Trademark Overview

On Wednesday, April 2, 2003, a trademark application was filed for GIBRALT with the United States Patent and Trademark Office. The USPTO has given the GIBRALT trademark a serial number of 78233093. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, January 23, 2007. This trademark is owned by Agouron Pharmaceuticals, Inc.. The GIBRALT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immunological disorders, viral disorders, HIV and AIDS

General Information

Serial Number78233093
Word MarkGIBRALT
Filing DateWednesday, April 2, 2003
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, January 23, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 4, 2003

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of immunological disorders, viral disorders, HIV and AIDS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, January 23, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgouron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAgouron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2007ABANDONMENT - AFTER PUBLICATION
Tuesday, January 23, 2007TEAS EXPRESS ABANDONMENT RECEIVED
Monday, January 8, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 20, 2006EXTENSION 5 GRANTED
Thursday, July 20, 2006EXTENSION 5 FILED
Thursday, July 20, 2006TEAS EXTENSION RECEIVED
Thursday, January 19, 2006EXTENSION 4 GRANTED
Thursday, January 19, 2006EXTENSION 4 FILED
Thursday, January 19, 2006TEAS EXTENSION RECEIVED
Tuesday, July 26, 2005EXTENSION 3 GRANTED
Tuesday, July 26, 2005EXTENSION 3 FILED
Tuesday, July 26, 2005TEAS EXTENSION RECEIVED
Wednesday, June 1, 2005ASSIGNED TO EXAMINER
Tuesday, May 31, 2005ASSIGNED TO EXAMINER
Monday, March 21, 2005ASSIGNED TO EXAMINER
Tuesday, March 8, 2005ASSIGNED TO EXAMINER
Monday, March 7, 2005ASSIGNED TO EXAMINER
Tuesday, January 25, 2005EXTENSION 2 GRANTED
Tuesday, January 25, 2005EXTENSION 2 FILED
Tuesday, January 25, 2005TEAS EXTENSION RECEIVED
Wednesday, August 11, 2004EXTENSION 1 GRANTED
Wednesday, July 21, 2004EXTENSION 1 FILED
Wednesday, July 21, 2004TEAS EXTENSION RECEIVED
Tuesday, January 27, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 4, 2003PUBLISHED FOR OPPOSITION
Wednesday, October 15, 2003NOTICE OF PUBLICATION
Tuesday, September 9, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 28, 2003ASSIGNED TO EXAMINER

Related Keywords

gibralt disorders viral aids immunological preparations treatment pharmaceutical